October 15, 2024

Ric Edelman - The Financial Implications of Alzheimer’s Disease (part 2)

Ric Edelman - The Financial Implications of Alzheimer’s Disease (part 2)

About This Episode

Long-term and health care costs for people living with Alzheimer's and other dementias are projected to reach $360 billion in the Unites States this year. In part 2 of the interview with Investment Advisor and New York Times Bestselling author Ric Edelman, host Meryl Comer asks about the financial challenges faced by families dealing with Alzheimer’s. Listen to the advice Edleman has about long-term care insurance and mistakes individuals commonly make in planning for retirement. You won’t want to miss this informative episode of BrainStorm!

BrainStorm by UsAgainstAlzheimer's is sponsored by Biogen and Eisai

Support the show

BrainStorm Feed

100

2025 Year in Review and Predictions for 2026 with George Vradenburg

George Vradenburg, Chairman and Founder of UsAgainstAlzheimer's, sits down with host Meryl Comer for a comprehensive look at the state of Alzheimer's research, advocacy, and care in 2025.
LISTEN NOW
99

The Future of Alzheimer's Trials: AI, Biomarkers, and Remote Research – John Dwyer, CEO of The Global Alzheimer’s Platform (part 2)

In part 2 John Dwyer, CEO of the Global Alzheimer's Platform (GAP), and BrainStorm host Meryl Comer discuss transforming Alzheimer's research and clinical trials.
LISTEN NOW
98

The Future of Alzheimer's Trials: Bringing Cutting-Edge Research to Every Community - John Dwyer, CEO of The Global Alzheimer's Platform

John Dwyer, CEO of the Global Alzheimer's Platform (GAP), highlights GAP's innovations in improving the participant experience through streamlining visits, personalized feedback, and bringing mobile trials directly to small communities.
LISTEN NOW